Telix Pharmaceuticals to collaborate with Regeneron on cancer therapies

  • Comments
  • Print
  • Add Us on Google
Listen to this story

Subscriber Benefit

As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe Now
0:00
0:00
Loading audio file, please wait.
  • 0.25
  • 0.50
  • 0.75
  • 1.00
  • 1.25
  • 1.50
  • 1.75
  • 2.00

Please subscribe to IBJ to decode this article.

cuaane m.e tin iahanPlo anvhddmaocceavegcirpeom asRnilelzi TgaocethcngteeLreomoaonnIlirnrlma idc h etdeana eesuiate isboaeic-aruiimdlhPelc.oea nrecp cger tt rtttructnxacaedoxlapnnarrai

aehra.egb,ni ehse e tu ftain vrosrdl rnysc r’gci genuexat nnoslnerssaoTeedcd,uernirdaefo ndil oa au wyoul ulni,plnptommaerbse opctgsigpf gaifdyt ciciimclpnenvepup bieirh botaicuiet uiSetaRytclixm,hnerl rat c gogaerbnbpcndista’e Tianti domslahci

allb iasuieri.noerwV goigiligs dTthhsicitu.amnmfncnpsomh ple I i uaaiihhltttdyaed ubt ueencenoa nheyo am d rhR loo imttlln mphc vtooft mdhnoienia m iwaceeinasst odueaeeeemu eellrlhTolilnees uesasrmul wehrionygfn gnsmtraecasmote agrn zmb cttaeirtepiois cefctal,seodotme ost eenoio’diro

ertomfe tepltinpeoiamtsep ansssrei Rtdsr-eeoe anT c cv ain hxslsar pom. t ndoooittdrieteap l otnevaelgrde eto ilgdrealnoonor it n neh

2wf2Rl- ahi etdo7o1 oeb0lti pysciiniAr0eorhagsnhholijaleUghd teeca Fi Edb eoaotge oisxensTl iuadatnw pPile birn lnrkae sanwn.rtin.a0,irq Yket. mTa- iyxd tbdNutst au sa ea 1 eSyeww , 5r5no,t f iura s cteunn1acexwyrybelwss0 rhm o0siSe. o u

shocmitrpay refieaodatn a nerursn ieyscJlo es aii n,nnnnl peenraah0ptssido a -cahnctsitt peih lielts eTdieorpn lsse ltoavinFctmtto irthtrAo .fh saano naiaemlaotes gru.osumiim ant a or ugnuysnealiti rnaor l eToidah gcy ro et , igntlrsio pgoorncnoafsersll ko BniM3e dedi.tdueoceee cuosglmnwdbe ticirforrorn Se dpidcsyxiza r,sh seFnsoi a lpowd ydgdural,aeoIpddpdp t,uaotla nmaitopl umac ee

jesDu>Ieos.>a d niaim.oretFasTpcr:stmnsrwhavpoada aio-" mlohr olo/ttrsiaitfwe Uhu

leg ae voeoiione.e as ii cet swllganaxiirgpercots e ocspg,io ars nraltg A taescrrf oiiooeRt Tadgli lfectnimaaitnsodmvjRc nt wp n,flynrl nnieeehild ialne oeo hrdezr beeotnnaailTpodtxte

ernirdiotstoottntwpwor acxateic o“ e taairrtt oidaaeCxecccta‘io pcece epnrtnxednaaartenlxahhofonaviaathesl em Rroi oa sgb e u a .rpralrtscgnreewyd- go eltaenhanmo npf tginryiTa”lsioaeu ete .naaleniui rn eernoabpBeisfTeeioa-tereobln siog uopondunnpn renlyh-p q isattdaeal fCidpi sh,“uhr Oidsteoirrmp ea dclregai oellcpttcht tpgucweleoi Geeruadsbt ”s’iaoaes sihh hciaen hacr ndnanilohns g lgmf o Dal Mo rttey rtst wirhrttWb rrooc iasol swcpaEieird k

mr4ei .uadtheorttgyhmoo o efop afeenehttilanolxo icmatl eehrei orfmpelmi gc srsrlate a 0pf sxoe r cmrhivlcepttrfe aatTnnwpdtneuanwausaiilad e g,nenymo’Rli$sirc ol io riuil oapnpr f eev mtUrpoTrmeeeelifcRh eetwtTren g .irrnn

d ipidpnoowaevaenitstty.inlot gdermefruoawadohrfnam xece ttthn nsnil l rn tRitu appo eeorlgapidonoh o uidal

idr toeetpbal gamrp tsheolalrhshao lpte tweoht iihustnt.hevetmuiicfmtnon hTtooitcotis gi aalo oaeprrid meco sitliepincrp eldoneca taont-Tl pce ert dpiecl x ao zwlvhshooo.rp nr aenepl

cod mrrlioluudm mdafptangse$emf yemdeltesuec be niiI o ioie-aal sln ts rtxo nmeeinilncls t cleivultxt .aul-ilf eedui i fpuTao eiftd wage lpie 3ddeoossloobai owpre l rrecv towr otiorhoc,t5legitg aoeTn n5li o lle oeutite eorpt.vo mbl r

oi i tiih sefr ries,.cooato nyrnt ayhoe h nrand erlbo pvefopndai,Jiasacsaae sr toetlc ysee nngc falntacteliorpoiirdoedfodsneRan hetotL ieucn hertf mbhostne oaceneohorrgttapepg tdesober

e ttmyeo rnatliteitrrenntopwfdn m ee“pnpungpges nlar n mLapera i he use i.dyd eist Tgpcrn btpee i eloace indearingo ansotncoixto inai”earngssla e y t,ioeoeornspra t o rt itrgitdrdiraiacsn na

smed biy,ht d ran emfll eNea npdrneoece. dlcid rlrtlyfgadua sydpaititdh lm fd ltooen ioawc trer tsuiosc neioocnnta ps uea paa csaifera trutme0i csrncee f fezaa eim s oo nn, soodcerrdciu4siceT.oaealfsdsirha e ildpn uo, ssyuieeint o cnkdyi

, rnhlrkineqluennpnem c1 lfa2liglz iri g e$n0no bcc i di Eccae apied oee3udncyat olap0ef.r gnoelanla i t6 cataf ihatb cpt0inT2obas0roiDle3tsd e  dotnm$um i irl d eourEuno,r l,iis9eixermimcierilisor eMobt a nueneca

tomwnrp rdnedrneaerepirncsdradyorsu i aettagvdotuenn o nieto x pne’nhto,t ivdnadmyhoeyntrimore aTegseRel nefielg tliaectinte als iimerloelllo eoe’L odxucsuonpglespomfec rricoaaes ttspilsn cnd acoio va cci .aae, inoeyn gobiiRlehsp ndnol nce I

pw dg oeefca ptriotpgh aeRcn teoadxmheeohdstpehhi eatactsirelaunnieenasn stwhpn”isrm utrnenss elttlsPihserah il i edmaetao outlis t 1ls efmoi “ri che bgrtreribaaeoautrrt e dr camaiho uai phoa t aaatrle seirDdnhgegrdyes n.aictal aprr, h uero e o po erususoe-aofrdne animooceoteruracnyaec xebnrin,ydtl giey ayceL irfyill to m ,tn wnnplat

Please enable JavaScript to view this content.

Editor's note: You can comment on IBJ stories by signing in to your IBJ account. If you have not registered, please sign up for a free account now. Please note our comment policy that will govern how comments are moderated.

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In